We are proud to share that researchers from the Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB) have been recognized among the top-cited authors in Multiple Sclerosis research, as highlighted by Wiley.
This recognition reflects the lasting impact of our work and the strength of our collaborative ecosystem, including clinical research, advanced neuroimaging, and biomarker development.
The featured publication in Annals of Neurology highlights the most influential contributions shaping the field:
https://onlinelibrary.wiley.com/doi/full/10.1002/ana.27096
Being among the most cited contributors shows RC2NB’s role in advancing Multiple Sclerosis research and turning scientific excellence into real-world impact for patients.
